BrightInsight

Digital tools key to immuno-oncology’s future: report

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down. As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper. The whitepaper, ‘The Role of Digital Health in Immuno-oncology Therapy Development and Adoption’ from …

Digital tools key to immuno-oncology’s future: report Read More »

Regulated digital health explained: What you need to know to stay compliant [Sponsored]

Digital health thought leader Mark Tarby, BrightInsight vice president of regulatory and quality management systems, shared his take on what the EU MDR means for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.

#Healthin2Point00, Episode 197 | BrightInsight, SteadyMD, CirrusMD, and Cleo

Today on Health in 2 Point 00, I’m getting my shots soon! On Episode 197, General Catalyst is throwing more money around – $101 million goes to BrightInsight for its digital health insights management platform. SteadyMD raises $25 million bringing its total to $31 million, and CirrusMD raises $20 million in a Series C bringing …

#Healthin2Point00, Episode 197 | BrightInsight, SteadyMD, CirrusMD, and Cleo Read More »

AstraZeneca presses forward with digital approach to managing chronic conditions

AstraZeneca is turning to digital technology to help patients and clinicians manage the treatment of chronic diseases. Though this technology isn’t tied to any AstraZeneca drug, the company believes such digital tools will become part of the new standard of care.

How digital health impacts the development and adoption of cancer immunotherapies [Sponsored]

In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.